2013 annual financial data
Rigel Pharmaceuticals 2013 Operating margin
Direct answer
Operating margin was -1,251.31%.
Operating income was -89,469,000 USD and net income was -89,027,000 USD.
Operating cash flow was -86,061,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,150,000 USD
- Operating income
- -89,469,000 USD
- Net income
- -89,027,000 USD
- Operating cash flow
- -86,061,000 USD